We get AI for work™: Preparing Real-World Healthcare Environments for an AI-Driven Future
DOL Compliance Tools & PBM Regulation, NLRB Intake Updates - #WorkforceWednesday® - Employment Law This Week®
Health-e Law Podcast, Episode 20 | J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
Podcast - Minority Deals in Healthcare Private Equity: An Evolving Opportunity for GPs and Founders Counsel That Cares Podcast Series
Pay Transparency + the Power of Preventive Strategies: Episode 3 — Pivoting Toward Preparation in the Life Sciences
Pay Transparency + the Power of Preventive Strategies: Episode 2 — Healthcare Compliance Crossroads
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 266: Navigating Today’s Healthcare Landscape with Leighton Roper of Maynard Nexsen
Hospice Insights Podcast - Reimagining How We Navigate Change and Loss: A Conversation with Sonya Dolan and Bridget Sumser of Mettle Health
Podcast - The Fast-Growing Wound Care Industry
Concierge Practices: Getting Started and Staying Compliant
Podcast - J.P. Morgan Healthcare Conference Recap: What Dealmakers Expect in 2026
Illinois Supreme Court Tightens Standing for No-Injury Consumer Claims — The Consumer Finance Podcast
Work This Way: A Labor & Employment Law Podcast | Service Animals, the ADA, and Workplace Rights
Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Private Equity Investment in Health Care
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — Payments Pros – The Payments Law Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — The Consumer Finance Podcast
AGG Talks: Government Insight for Life Sciences Leaders | Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies
Season 2, Episode 2: Reimagining Employer-Sponsored Healthcare with Jack Hill of Nomi Health In this episode of BRight Minds in Healthcare Delivery, host Eric Tower speaks with Jack Hill, Senior Vice President of Enterprise...more
Key Takeaways - CMS is seeking input by March 30 on a proposed framework to promote U.S.-made PPE and essential medicines in Medicare-participating hospitals....more
Overview of Required NPP Changes: 42 C.F.R. Part 2 applies to patient records created by, received or acquired by any federally assisted program that provides diagnosis, treatment or referral for treatment of a substance...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
On February 6, 2026, New York Governor Kathy Hochul signed the Medical Aid in Dying Act (the “Act”) into law, establishing a statutory framework under which certain terminally ill adults may request and obtain medication to...more
Operating at full capacity thus far this year, the U.S. Food and Drug Administration (“FDA” or “agency”) Office of Prescription Drug Promotion (“OPDP”) has so far released seven untitled letters, reminding the industry that...more
In 2010, the Obama Administration largely disrupted the healthcare industry with its landmark legislation, the Affordable Care Act. We are in another such moment, where the Trump Administration is transforming the life...more
The U.S. Food and Drug Administration (FDA) announced several coordinated updates on February 5, 2026, that collectively signal a major shift in the agency’s oversight of “no artificial colors” claims on foods intended for...more
One of the characteristics of the response to the COVID-19 pandemic were the pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to enforce patents on relevant technology...more
Last month, Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services (“CMS”), accompanied by other CMS officials, visited with home health and hospice providers and related industry associations to discuss...more
Ares’ Private Equity Group (Ares) and DaVita will make a strategic investment in Elara Caring, according to a news release. Elara, founded in 1975 and based in Dallas, is a provider of home care, offering skilled home...more
On February 5, 2026, the Massachusetts Health Policy Commission (the “HPC”) released its long-awaited amended regulation to 958 CMR 7.00 (the “Proposed Amended Regulation”) to align the existing regulation with the changes...more
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) issued a special advisory bulletin applying the federal Anti-Kickback Statute to a pharmaceutical manufacturer’s offer...more
On February 5, 2026, Florida Attorney General James Uthmeier announced the creation of a dedicated “Consumer Harm from International Nefarious Actors” (CHINA) Prevention Unit within the Florida Office of the Attorney General....more
In 2026, each state will receive a federal award through the Rural Health Transformation (“RHT”) Program, a five-year program authorized by Congress in 2025....more
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary...more
The Centers for Medicare & Medicaid Services (CMS) allows the use of real-time, two-way audio/video communications technology to satisfy the direct supervision requirement for most Medicare Part B services. This development,...more
On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers (PBMs). Under the terms of...more
On February 10, 2026, the U.S. Food and Drug Administration (FDA) announced the launch of a comprehensive reassessment of butylated hydroxyanisole (BHA), an ingredient typically used in food as an antioxidant to prevent the...more
As outlined in our previous post, the Department of Health and Human Services (HHS) has issued a significant Request for Information (RFI) seeking broad public comment on how the agency can accelerate the adoption and use of...more
On January 28, 2026, the U.S. Department of Health and Human Services Office of Inspector General (“HHS OIG”) released a report, “Total Medicare Part B Spending on Lab Tests Rose in 2024, Driven by Increased Spending on...more
Last week, on February 3, 2026, Congress passed the Consolidated Appropriations Act (“the Act”), providing generic drug manufacturers much-needed clarity as to when inactive ingredients in an ANDA are qualitatively and...more
For several years the distribution of profit within the Dutch healthcare sector has been the subject of public and political debate. The discussion has intensified as private equity investment in healthcare has grown, raising...more
On January 11, 2026, the FDA issued two news releases putting forward reforms to the chemistry, manufacturing, and control requirements for cell and gene therapy products, one titled FDA Increases Flexibility on Requirements...more
A newly introduced House Bill, H.R. 7366, titled the Dietary Supplement Regulatory Uniformity Act, would amend the Federal Food, Drug, and Cosmetic Act (“FDCA”) to expressly clarify and affirm the Food and Drug...more
